Category: Latest News
-
Rocket Pharmaceuticals Shares Jump After FDA Grants Accelerated Review Status to Gene Therapy
Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) surged 15% after receiving a key regulatory boost from the U.S. Food and Drug Administration (FDA), which granted its investigational gene therapy RP-A601 the Regenerative Medicine Advanced Therapy (RMAT) designation. The therapy is being developed to treat PKP2-arrhythmogenic cardiomyopathy (PKP2-ACM), a rare and potentially fatal inherited heart condition associated with arrhythmias…
-
LQR House Shares Slide After Lawsuit Seeks Asset Freeze and Court-Appointed Receiver
Shares of LQR House Inc. (NASDAQ:LQR) sank 24% on Thursday following news that the company has been named in a lawsuit requesting an asset freeze and court oversight of its operations. Filed by Kingbird Ventures, LLC in Nevada’s Eighth Judicial District Court on July 11, the suit targets LQR House and its full board of…
-
Disco Posts Solid Q1 Earnings, Sees Q2 Shipment Slowdown Amid Front-Loaded Demand
Disco Corporation (USOTC:DSCSY) reported robust first-quarter results, with revenue climbing to ¥89.9 billion—an 8.6% year-over-year increase—and operating profit reaching ¥34.4 billion, up 3.3%. The figures follow a recent guidance revision announced on July 9. The company’s operating profit came in roughly ¥10 billion higher than internal forecasts, excluding currency effects, with an additional ¥4 billion…
-
Volcon Shares Surge Over 300% Following $500M Bitcoin-Focused Private Placement
Volcon Inc. (NASDAQ:VLCN) shares soared more than 300% after the electric off-road vehicle maker announced a dramatic shift in strategy, fueled by a $500 million private placement aimed at building a substantial Bitcoin treasury. The Austin-based company disclosed that it has entered into securities purchase agreements with institutional and accredited investors to sell roughly 50.1…
-
Digi Power X Shares Jump After Securing Supermicro Systems for AI Infrastructure Expansion
Digi Power X Inc. (NASDAQ:DGXX) saw its stock climb 11% after announcing a major equipment purchase aimed at boosting its AI capabilities. The company has placed a purchase order with Super Micro Computer Inc. (NASDAQ:SMCI) for systems powered by NVIDIA’s (NASDAQ:NVDA) B200 GPUs, which will support its NeoCloud AI platform. These Supermicro units will be…
-
Cintas Tops Q4 Estimates as Revenue and Margins Improve
Cintas Corporation (NASDAQ:CTAS) reported stronger-than-expected fourth-quarter results on Thursday, driven by solid sales momentum and improved profitability. The company also released guidance for its upcoming fiscal year. For the quarter ending May 31, Cintas earned $1.09 per share, exceeding analyst expectations by $0.02. Revenue climbed 8% year-over-year to $2.67 billion, surpassing Wall Street estimates. Shares…
-
Above Food Shares Skyrocket After Merger Injects Billions in Gold Assets
Above Food Ingredients Inc. (NASDAQ:ABVE) shares surged 65% after the company announced a transformative reverse takeover deal with Palm Global Technologies Ltd. The merger, unanimously approved by both boards, will significantly reshape Above Food’s business by bringing gold-backed assets worth billions onto its balance sheet. The transaction includes Palm Global’s 30% interest in Palm Promax…
-
Adtran Shares Climb Further as Analysts Highlight Improving Outlook
Adtran Holdings (NASDAQ:ADTN) saw its stock rise another 2.9% in Thursday’s premarket session, extending the 9.2% jump from the day before. The rally followed the company’s release of stronger-than-expected preliminary revenue for the second quarter. Analysts at Needham remain upbeat on the company’s trajectory. Ryan Koontz, a Needham analyst, suggested that Adtran could deliver third-quarter…
-
Nuwellis Shares Drop as Company Halts REVERSE-HF Clinical Trial
Nuwellis Inc (NASDAQ:NUWE) saw its stock decline by 10% after announcing it will discontinue its REVERSE-HF clinical trial, which was assessing the effectiveness of ultrafiltration versus intravenous loop diuretics for managing fluid overload in hospitalized heart failure patients. The company explained that ending the trial is part of a broader effort to concentrate resources on…
-
Lucid Shares Skyrocket on Strategic Deal with Uber and Nuro for Autonomous Robotaxis
Lucid Group (NASDAQ:LCID) stock soared by 35% after unveiling a landmark partnership with Uber Technologies (NYSE:UBER) and autonomous vehicle company Nuro to roll out a large-scale robotaxi initiative. The multi-year collaboration is set to bring more than 20,000 Lucid vehicles outfitted with Nuro’s Level 4 autonomous driving technology to the Uber platform over a six-year…